The Indiana-based medical device company that got Tom Price into hot water as a nominee for his current position, Secretary of Health and Human Services, would benefit greatly from a new Medicare payment proposal.

The company, Zimmer Biomet Holdings Inc., along with others that make parts for ankle replacement surgeries, would get more than 60% more, on average, from Medicare under the proposal. News site Axios first reported the connection on Tuesday.

Price, a former orthopedic surgeon, bought shares in Zimmer Biomet ZBH, -3.35% before introducing legislation that would have helped the company, CNN reported in January. Price invested between $1,001 and $15,000 in the company, on which he made no income, or less than $201, according to a financial disclosure made when he was a nominee.

Price said then that he would divest his stock in various companies, including Zimmer Biomet, within 90 days of his February 10 confirmation. A HHS spokesperson told MarketWatch that Price has done that.

See more: Trump HHS secretary nominee Tom Price rebuts accusations of improper stock buys

The rule, which was released on Friday afternoon and proposes 2018 payment rates for hospitals, would also benefit companies such as Stryker Corp. SYK, -2.21% , Wright Medical Group WMGI, -0.06% and doctors performing the surgeries, according to Axios. The proposal is open for comments through June 13.

Centers for Medicare and Medicaid Services, which is under HHS, said in the rule that it got two requests for ankle replacements to be classified differently from total hip and knee replacement procedures.

Related: Democrats blast Price over share purchase ahead of confirmation hearing

Trump’s HHS Pick: No Cuts to Medicare, Medicaid Expected

The parties that made the requests — who aren’t identified in the rule — said “there are significant clinical and cost differences among these procedures, which results in underpayment for [total ankle replacement procedures],” according to the rule.

Among other differences, the requestors said that “the unique anatomical characteristics and function of the ankle joint require a specialized surgical skill set, operative technique, and level of operating room resource utilization that is vastly dissimilar from that of total hip and knee replacement procedures.”

CMS said that after examining claims data, it agreed.

Before serving as a congressman, Price worked for many years as an orthopedic surgeon, a job that specializes in the musculoskeletal system. Orthopedic surgeons can specialize in areas such as the foot and ankle, or other parts of the body.

Zimmer Biomet shares were down 0.9% in Tuesday morning trade. Shares have risen 4.0% over the last three months, compared with a 3.2% rise in the S&P 500 SPX, -1.42% .

This story was first published on Tuesday.